Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06362018
Status:
RECRUITING
Last Update Posted:
2024-05-09
First Post:
2024-04-02
Brief Title:
Bioavailability of Three Mitopure Formulations
Sponsor:
Amazentis SA
Organization:
Amazentis SA
Study Overview
Official Title:
A Comparative Pharmacokinetic Profiles of Three Urolithin A Formulations in Healthy Volunteers A Randomized Open-label Single-dose Parallel-arm Study
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This studys design as an open-label single-dose randomized trial that aligns with the objective of characterizing the concentration-time profiles of three Urolithin A Mitopure formulations in a controlled setting The inclusion criteria stringent fasting requirements standardized fluid intake and strict dietary restriction protocols ensure homogeneity among the study participants enhancing the reliability of the outcomes
Ultimately this clinical trial aims to contribute valuable insights into the pharmacokinetic behavior of the different Urolithin A formulations facilitating informed decisions for future developments and applications in the realm of health and wellness
Ultimately this clinical trial aims to contribute valuable insights into the pharmacokinetic behavior of the different Urolithin A formulations facilitating informed decisions for future developments and applications in the realm of health and wellness
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| MHCCT23-24055 Version No | OTHER | Mprex Healthcare Pvt Ltd | None |